User menu

Differential association of calreticulin type 1 and type 2 mutations with myelofibrosis and essential thrombocytemia: relevance for disease evolution.

Bibliographic reference Cabagnols, X ; Defour, Jean-Philippe ; Ugo, V ; Ianotto, J C ; Mossuz, P ; et. al. Differential association of calreticulin type 1 and type 2 mutations with myelofibrosis and essential thrombocytemia: relevance for disease evolution.. In: Leukemia, Vol. 29, no. 1, p. 249-252 (2014)
Permanent URL http://hdl.handle.net/2078.1/155936
  1. Klampfl Thorsten, Gisslinger Heinz, Harutyunyan Ashot S., Nivarthi Harini, Rumi Elisa, Milosevic Jelena D., Them Nicole C.C., Berg Tiina, Gisslinger Bettina, Pietra Daniela, Chen Doris, Vladimer Gregory I., Bagienski Klaudia, Milanesi Chiara, Casetti Ilaria Carola, Sant'Antonio Emanuela, Ferretti Virginia, Elena Chiara, Schischlik Fiorella, Cleary Ciara, Six Melanie, Schalling Martin, Schönegger Andreas, Bock Christoph, Malcovati Luca, Pascutto Cristiana, Superti-Furga Giulio, Cazzola Mario, Kralovics Robert, Somatic Mutations of Calreticulin in Myeloproliferative Neoplasms, 10.1056/nejmoa1311347
  2. Nangalia J., Massie C.E., Baxter E.J., Nice F.L., Gundem G., Wedge D.C., Avezov E., Li J., Kollmann K., Kent D.G., Aziz A., Godfrey A.L., Hinton J., Martincorena I., Van Loo P., Jones A.V., Guglielmelli P., Tarpey P., Harding H.P., Fitzpatrick J.D., Goudie C.T., Ortmann C.A., Loughran S.J., Raine K., Jones D.R., Butler A.P., Teague J.W., O'Meara S., McLaren S., Bianchi M., Silber Y., Dimitropoulou D., Bloxham D., Mudie L., Maddison M., Robinson B., Keohane C., Maclean C., Hill K., Orchard K., Tauro S., Du M.-Q., Greaves M., Bowen D., Huntly B.J.P., Harrison C.N., Cross N.C.P., Ron D., Vannucchi A.M., Papaemmanuil E., Campbell P.J., Green A.R., Somatic CALR Mutations in Myeloproliferative Neoplasms with Nonmutated JAK2, 10.1056/nejmoa1312542
  3. Levine R. L., Gilliland D. G., Myeloproliferative disorders, 10.1182/blood-2008-03-077966
  4. Campbell Peter J, Scott Linda M, Buck Georgina, Wheatley Keith, East Clare L, Marsden Joanne T, Duffy Audrey, Boyd Elaine M, Bench Anthony J, Scott Mike A, Vassiliou George S, Milligan Donald W, Smith Steve R, Erber Wendy N, Bareford David, Wilkins Bridget S, Reilly John T, Harrison Claire N, Green Anthony R, Definition of subtypes of essential thrombocythaemia and relation to polycythaemia vera based on JAK2 V617F mutation status: a prospective study, 10.1016/s0140-6736(05)67785-9
  5. Beer P. A., Campbell P. J., Scott L. M., Bench A. J., Erber W. N., Bareford D., Wilkins B. S., Reilly J. T., Hasselbalch H. C., Bowman R., Wheatley K., Buck G., Harrison C. N., Green A. R., MPL mutations in myeloproliferative disorders: analysis of the PT-1 cohort, 10.1182/blood-2008-01-131664
  6. James Chloé, Ugo Valérie, Le Couédic Jean-Pierre, Staerk Judith, Delhommeau François, Lacout Catherine, Garçon Loïc, Raslova Hana, Berger Roland, Bennaceur-Griscelli Annelise, Villeval Jean Luc, Constantinescu Stefan N., Casadevall Nicole, Vainchenker William, A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera, 10.1038/nature03546
  7. Baxter E Joanna, Scott Linda M, Campbell Peter J, East Clare, Fourouclas Nasios, Swanton Soheila, Vassiliou George S, Bench Anthony J, Boyd Elaine M, Curtin Natasha, Scott Mike A, Erber Wendy N, Green Anthony R, Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders, 10.1016/s0140-6736(05)71142-9
  8. Chi J, Nicolaou K A, Nicolaidou V, Koumas L, Mitsidou A, Pierides C, Manoloukos M, Barbouti K, Melanthiou F, Prokopiou C, Vassiliou G S, Costeas P, Calreticulin gene exon 9 frameshift mutations in patients with thrombocytosis, 10.1038/leu.2013.382
  9. Lundberg P., Karow A., Nienhold R., Looser R., Hao-Shen H., Nissen I., Girsberger S., Lehmann T., Passweg J., Stern M., Beisel C., Kralovics R., Skoda R. C., Clonal evolution and clinical correlates of somatic mutations in myeloproliferative neoplasms, 10.1182/blood-2013-11-537167
  10. Maffioli M, Genoni A, Caramazza D, Mora B, Bussini A, Merli M, Giorgino T, Casalone R, Passamonti F, Looking for CALR mutations in familial myeloproliferative neoplasms, 10.1038/leu.2014.33
  11. Rumi E., Harutyunyan A. S., Pietra D., Milosevic J. D., Casetti I. C., Bellini M., Them N. C. C., Cavalloni C., Ferretti V. V., Milanesi C., Berg T., Sant'Antonio E., Boveri E., Pascutto C., Astori C., Kralovics R., Cazzola M., , CALR exon 9 mutations are somatically acquired events in familial cases of essential thrombocythemia or primary myelofibrosis, 10.1182/blood-2014-01-550434
  12. Tefferi A, Finke C M, Lasho T L, Wassie E A, Knudson R, Ketterling R P, Hanson C A, Pardanani A, U2AF1 mutations in primary myelofibrosis are strongly associated with anemia and thrombocytopenia despite clustering with JAK2V617F and normal karyotype, 10.1038/leu.2013.286
  13. Tefferi Ayalew, Wassie Emnet A., Guglielmelli Paola, Gangat Naseema, Belachew Alem A., Lasho Terra L., Finke Christy, Ketterling Rhett P., Hanson Curtis A., Pardanani Animesh, Wolanskyj Alexandra P., Maffioli Margherita, Casalone Rosario, Pacilli Annalisa, Vannucchi Alessandro M., Passamonti Francesco, Type 1 versus Type 2 calreticulin mutations in essential thrombocythemia: A collaborative study of 1027 patients : Type 1 vs. type 2 CALR Mutations in ET, 10.1002/ajh.23743
  14. Rampal R., Al-Shahrour F., Abdel-Wahab O., Patel J. P., Brunel J.-P., Mermel C. H., Bass A. J., Pretz J., Ahn J., Hricik T., Kilpivaara O., Wadleigh M., Busque L., Gilliland D. G., Golub T. R., Ebert B. L., Levine R. L., Integrated genomic analysis illustrates the central role of JAK-STAT pathway activation in myeloproliferative neoplasm pathogenesis, 10.1182/blood-2014-02-554634